We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb Stresses Importance of Patient Voice in Benefit-Risk Assessments
Gottlieb Stresses Importance of Patient Voice in Benefit-Risk Assessments
FDA Commissioner Scott Gottlieb announced an update of the agency’s framework for using benefit-risk assessments in drug reviews and said he wants to improve the assessments by making increased use of patient perspectives.